Schedule 13D ownership disclosure

TENAX THERAPEUTICS INC

Security class unavailable · CUSIP: 88032L209

Event date: 2021-06-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,637,871
Percent of class
14.4400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001654954-21-007129
Form type
SC 13D
Filer
Doogan Declan
CIK
CIK 1704234
Filed
Jun 22, 2021
Reporting period
Jun 11, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub